nad has been researched along with oxidopamine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruchelt, G; Cochrane, CG; Niethammer, D; Schraufstätter, IU | 1 |
| Frei, B; Richter, C | 1 |
| Girardier, L; Mory, G; Seydoux, J | 1 |
| Dabbeni-Sala, F; Franceschini, D; Giusti, P; Skaper, SD | 1 |
| Baudry, M; Fonck, C | 1 |
| Ceña, V; Galindo, MF; González-García, C; Jordán, J | 1 |
| Bobalova, J; Lew, C; Mendoza, MG; Mutafova-Yambolieva, VN; Smyth, LM | 1 |
| Cai, AL; Sheline, CT; Shi, C; Zhang, W; Zhu, J | 1 |
| Gong, YL; Hou, YF; Huang, GR; Li, ST; Liu, JM; Shan, C; Sun, LH; Tao, B; Wang, SM; Zhao, HY; Zhu, Q; Zhuang, QQ | 1 |
| Liang, Y; Meng, J; Min, D; Qin, Z; Wang, Y; Yu, J; Yu, Y | 1 |
10 other study(ies) available for nad and oxidopamine
| Article | Year |
|---|---|
Ascorbic acid enhances the effects of 6-hydroxydopamine and H2O2 on iron-dependent DNA strand breaks and related processes in the neuroblastoma cell line SK-N-SH.
Topics: Adenosine Triphosphate; Ascorbic Acid; DNA; DNA Damage; Humans; Hydrogen Peroxide; Iron; NAD; Neuroblastoma; Oxidopamine; Poly(ADP-ribose) Polymerases; Tumor Cells, Cultured | 1991 |
N-methyl-4-phenylpyridine (MMP+) together with 6-hydroxydopamine or dopamine stimulates Ca2+ release from mitochondria.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Calcium; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Dopamine; Egtazic Acid; Female; Hydroxydopamines; In Vitro Techniques; Mitochondria; NAD; Oxidopamine; Parkinson Disease, Secondary; Pyridines; Pyridinium Compounds; Rats; Rats, Inbred Strains | 1986 |
Short-lived denervation of brown adipose tissue of the rat induced by chemical sympathetic denervation.
Topics: Adipose Tissue, Brown; Animals; Caprylates; DNA; Electric Stimulation; Guanethidine; Hydroxydopamines; Male; NAD; NADP; Norepinephrine; Organ Size; Oxidation-Reduction; Oxidopamine; Rats; Rats, Inbred Strains; Sympathectomy, Chemical | 1981 |
Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity.
Topics: Adenosine Triphosphatases; Animals; Apomorphine; Behavior, Animal; Disease Models, Animal; Electron Transport Complex IV; Electrophoresis, Polyacrylamide Gel; Male; Melatonin; Mitochondria; Motor Activity; NAD; Neuroprotective Agents; Oxidative Phosphorylation; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Substantia Nigra | 2001 |
Toxic effects of MPP(+) and MPTP in PC12 cells independent of reactive oxygen species formation.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Cell Differentiation; Cell Survival; Dopamine; Dopamine Agents; Drug Interactions; Free Radical Scavengers; Herbicides; Lipid Peroxidation; NAD; Nerve Growth Factor; Neurons; Oxidopamine; Parkinsonian Disorders; PC12 Cells; Rats; Reactive Oxygen Species; Substantia Nigra; Tritium | 2001 |
Chromaffin cell death induced by 6-hydroxydopamine is independent of mitochondrial swelling and caspase activation.
Topics: Animals; Antioxidants; Caspases; Cattle; Cells, Cultured; Chromaffin Cells; Dose-Response Relationship, Drug; Hydrogen Peroxide; Mitochondria; NAD; NADP; Oxidation-Reduction; Oxidopamine; Quinones; Reactive Oxygen Species | 2003 |
Release of beta-nicotinamide adenine dinucleotide upon stimulation of postganglionic nerve terminals in blood vessels and urinary bladder.
Topics: Acetaldehyde; Adenine; Adenosine Triphosphate; Adrenergic Agents; Anesthetics, Local; Animals; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Cyclic ADP-Ribose; Dogs; Electrochemistry; Electrophysiology; Female; Guanethidine; Guinea Pigs; Hydrogen-Ion Concentration; Male; Mesenteric Arteries; Mice; Models, Chemical; Muscle, Smooth; NAD; Norepinephrine; omega-Conotoxin GVIA; Oxidopamine; Rabbits; Rats; Rats, Wistar; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Stress, Mechanical; Temperature; Tetrodotoxin; Time Factors; Urinary Bladder | 2004 |
Mitochondrial inhibitor models of Huntington's disease and Parkinson's disease induce zinc accumulation and are attenuated by inhibition of zinc neurotoxicity in vitro or in vivo.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carrier Proteins; Cation Transport Proteins; Cell Death; Cells, Cultured; Cerebral Cortex; Dihydroxyacetone Phosphate; Disease Models, Animal; Drug Interactions; Embryo, Mammalian; Fructose-Bisphosphatase; Humans; Huntington Disease; Male; Matrix Metalloproteinase 16; Membrane Proteins; Membrane Transport Proteins; Mental Disorders; Mice; Mice, Inbred C57BL; Mice, Neurologic Mutants; Mice, Transgenic; NAD; Neurons; Niacinamide; Nitro Compounds; Oxidopamine; Parkinson Disease; Propionates; Pyruvic Acid; Rats; Rats, Long-Evans; Tyrosine 3-Monooxygenase; Zinc | 2013 |
Protective effects of β- nicotinamide adenine dinucleotide against motor deficits and dopaminergic neuronal damage in a mouse model of Parkinson's disease.
Topics: Animals; Cell Survival; Cells, Cultured; Corpus Striatum; Disease Models, Animal; Dopaminergic Neurons; Humans; Male; Mice; Microinjections; Mitochondria; Motor Activity; NAD; Nerve Degeneration; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease, Secondary | 2019 |
Dysbiosis of gut microbiota inhibits NMNAT2 to promote neurobehavioral deficits and oxidative stress response in the 6-OHDA-lesioned rat model of Parkinson's disease.
Topics: Animals; Dysbiosis; Gastrointestinal Microbiome; NAD; Nicotinamide-Nucleotide Adenylyltransferase; Oxidative Stress; Oxidopamine; Parkinson Disease; Rats | 2023 |